Drug Profile


Alternative Names: HMR 1883

Latest Information Update: 03 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Antiarrhythmics
  • Mechanism of Action Potassium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Heart arrest; Ventricular arrhythmias

Most Recent Events

  • 18 Jun 2002 Discontinued - Phase-I for Heart arrest in USA (unspecified route)
  • 18 Jun 2002 Discontinued - Phase-II for Heart arrest in Germany (unspecified route)
  • 18 Jun 2002 Discontinued - Phase-II for Ventricular arrhythmias in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top